JP2020002127A - Esculin lipoic acid ester with antioxidant activity and method of preparing the same - Google Patents

Esculin lipoic acid ester with antioxidant activity and method of preparing the same Download PDF

Info

Publication number
JP2020002127A
JP2020002127A JP2019115839A JP2019115839A JP2020002127A JP 2020002127 A JP2020002127 A JP 2020002127A JP 2019115839 A JP2019115839 A JP 2019115839A JP 2019115839 A JP2019115839 A JP 2019115839A JP 2020002127 A JP2020002127 A JP 2020002127A
Authority
JP
Japan
Prior art keywords
esculin
compound
reaction mixture
lipoic acid
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019115839A
Other languages
Japanese (ja)
Other versions
JP6741315B2 (en
Inventor
クィアン,タオタオ
Taotao Qiang
ソン,ユンイン
Yunying Song
レン,ロンファン
Longfang Ren
ワン,シュエチュアン
Xuechuan Wang
リャン,チェンユアン
Chengyuan Liang
ティアン,レイ
Lei Tian
ジュ,シンクー
Xinke Ju
リ,ハン
Hang Li
ジャオ,チエンチエン
Qianqian Zhao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shaanxi University of Science and Technology
Original Assignee
Shaanxi University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shaanxi University of Science and Technology filed Critical Shaanxi University of Science and Technology
Publication of JP2020002127A publication Critical patent/JP2020002127A/en
Application granted granted Critical
Publication of JP6741315B2 publication Critical patent/JP6741315B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)

Abstract

To provide an antioxidant as a food and cosmetic additive, and a method of preparing the same.SOLUTION: The invention provides the esculin lipoic acid ester compound represented by formula I in the figure.SELECTED DRAWING: Figure 1

Description

本発明は、2018年6月22日に出願された中国特許出願第CN201810649366.X号に対する優先権を主張し、その内容は、本明細書に完全に記載されているかのようにあらゆる目的のために参照することにより援用される。   The present invention relates to Chinese Patent Application No. CN201810649366. Filed on June 22, 2018. Claims priority to Issue X, the contents of which are incorporated by reference for all purposes as if fully set forth herein.

本発明は食品および化粧品添加剤、特に酸化防止活性を有するエスクリンリポ酸エステルおよびその製造方法に関する。   The present invention relates to food and cosmetic additives, particularly to esculin lipoate having antioxidant activity and a method for producing the same.

食品添加物産業の技術的進歩のために、食品酸化防止剤の開発、製造、および適用が非常に進歩している。酸化防止剤は重要な食品添加物である。これは主に食品中の油の自動酸化を防止または遅延させるために使用される。それはまた貯蔵中の酸化による、栄養素の損傷、褐変、および退色を防止する。同時に、近年、研究によって、酸化および紫外線照射によって人間の肌が老化することが明らかになっているので、化粧品業界ではますます多くの酸化防止剤も使用されている。新しい酸化防止剤を開発するために、さらに研究が進められている。合成酸化防止剤および半合成酸化防止剤がますます注目を集めている。   Due to technological advances in the food additive industry, the development, manufacture, and application of food antioxidants have greatly advanced. Antioxidants are important food additives. It is mainly used to prevent or delay the autoxidation of oils in foods. It also prevents nutrient damage, browning, and fading due to oxidation during storage. At the same time, more and more antioxidants are also used in the cosmetics industry, as research has shown in recent years that human skin ages due to oxidation and UV irradiation. Further research is underway to develop new antioxidants. Synthetic and semi-synthetic antioxidants are receiving increasing attention.

エスクリン(式IIの化合物)は、モクセイ属のオレインツリーの乾燥樹皮または乾燥表皮から抽出されたクマリン化合物であり、漢方薬Qinpi(Cortex Fraxini)の有効成分である。エスクリンには、抗炎症作用、抗菌作用、利尿作用、および抗腫瘍作用がある。酸化防止剤としてのエスクリンの使用に関する報告は無い。

Figure 2020002127
Esculin (a compound of formula II) is a coumarin compound extracted from the dried bark or dried epidermis of the olein tree of the genus Oleaceae, and is an active ingredient of the Chinese herbal medicine Qinpi (Cortex Fraxini). Esculin has anti-inflammatory, antibacterial, diuretic, and antitumor effects. There are no reports on the use of esculin as an antioxidant.
Figure 2020002127

リポ酸(α−リポ酸およびアルファリポ酸としても知られている、式IIIの化合物)はミトコンドリア中に存在する補酵素であり、ビタミンと同様に、老化および病気を加速するフリーラジカルを排除する。リポ酸は、体内で腸に吸収された後に細胞に入る。それは脂溶性および水溶性の両方の性質を有する。それは心臓病や糖尿病などの様々な病気の治療と予防に使用されている。それはビタミンCおよびEのような他の酸化防止剤を保存し、再生すると考えられている。

Figure 2020002127
Lipoic acid (a compound of formula III, also known as alpha-lipoic acid and alpha-lipoic acid) is a coenzyme present in mitochondria that, like vitamins, eliminates free radicals that accelerate aging and disease . Lipoic acid enters cells after being absorbed by the gut in the body. It has both fat-soluble and water-soluble properties. It has been used in the treatment and prevention of various diseases such as heart disease and diabetes. It is believed to preserve and regenerate other antioxidants such as vitamins C and E.
Figure 2020002127

一実施形態では、本発明は、以下の式Iの化合物(エスクリンリポ酸エステル)を提供する。

Figure 2020002127
In one embodiment, the present invention provides a compound of formula I (esculin lipoate):
Figure 2020002127

一実施形態では、本発明は、式Iの化合物を調製する方法を提供する。当該方法は、式IIの化合物を式IIIの化合物と反応させて式Iの化合物を得ることを含む。

Figure 2020002127
In one embodiment, the present invention provides a method for preparing a compound of formula I. The method comprises reacting a compound of formula II with a compound of formula III to obtain a compound of formula I.
Figure 2020002127

別の実施形態において、式IIの化合物と式IIIの化合物との反応は、式IIの化合物と式IIIの化合物とを1:1〜1:1.3のモル比で反応器内に配する工程、有機溶媒、N,N´−ジシクロヘキシルカルボジイミド(DCC)、および触媒を添加して反応混合物を得る工程、ならびに、超音波処理下で当該反応混合物を30〜55℃で3〜4時間加熱する工程、を含む。   In another embodiment, the reaction of the compound of Formula II with the compound of Formula III places the compound of Formula II and the compound of Formula III in a molar ratio of 1: 1 to 1: 1.3 in the reactor. Adding an organic solvent, N, N'-dicyclohexylcarbodiimide (DCC), and a catalyst to obtain a reaction mixture, and heating the reaction mixture under sonication at 30-55 ° C. for 3-4 hours. Process.

他の実施形態において、有機溶媒はアセトニトリルまたはTHFであり、かつ、触媒は塩化ベンジルトリエチルアンモニウムまたは塩化チオニルである。   In another embodiment, the organic solvent is acetonitrile or THF, and the catalyst is benzyltriethylammonium chloride or thionyl chloride.

前述の一般的な説明および以下の詳細な説明は両方とも例示的かつ説明的なものであり、特許請求の範囲に記載された本発明をさらに説明するためのものであることを理解されたい。   It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory and are intended to provide further explanation of the invention as claimed.

本発明のさらなる理解を提供するために含まれ、本明細書に組み込まれてその一部を構成する添付の図面は、本発明の実施形態を例示し、その説明とともに本発明の原理を説明するのに役立つ。   The accompanying drawings, which are included to provide a further understanding of the invention, and are incorporated in and constitute a part of this specification, illustrate embodiments of the invention and, together with the description, explain the principles of the invention. Help.

異なる濃度におけるサンプルおよび対照溶液のスカベンジング活性Scavenging activity of sample and control solutions at different concentrations

ここで本発明の実施形態を詳細に参照するが、その例は添付の図面に示されている。以下の実施例は本発明を説明するが、本発明は以下の実施例に限定されない。   Reference will now be made in detail to embodiments of the invention, examples of which are illustrated in the accompanying drawings. The following examples illustrate the invention, but the invention is not limited to the examples.

〔実施例1〕
エスクリンリポ酸エステル(式Iの化合物)の調製
[Example 1]
Preparation of esculin lipoate (compound of formula I)

エスクリン100mg(0.29mmol)およびリポ酸66.6mg(0.32mmol)を100mL反応器に入れた。アセトニトリル60mLを添加して反応混合物を形成した。次いで、DCC61.9mg(0.3mmol)および塩化チオニル3.5mgを反応混合物に添加した。反応混合物を超音波処理および窒素雰囲気下で35℃で4時間加熱した。反応混合物を室温に冷却し、減圧下で濃縮し、濾過し、硫酸ナトリウムで乾燥した。次いで反応混合物中の溶媒を除去して、エスクリンリポ酸エステル137.9mgを得た(収率88.79%)。   100 mg (0.29 mmol) of esculin and 66.6 mg (0.32 mmol) of lipoic acid were placed in a 100 mL reactor. 60 mL of acetonitrile was added to form a reaction mixture. Then 61.9 mg (0.3 mmol) of DCC and 3.5 mg of thionyl chloride were added to the reaction mixture. The reaction mixture was heated at 35 ° C. under sonication and nitrogen atmosphere for 4 hours. The reaction mixture was cooled to room temperature, concentrated under reduced pressure, filtered, and dried over sodium sulfate. Then, the solvent in the reaction mixture was removed to obtain 137.9 mg of esculin lipoate (88.79% yield).

1H NMR (400 MHz, DMSO-d6) δ (ppm): 7.74 (1H, d), 6.87(1H, s), 6.73 (1H, s), 5.90 (1H, d), 5.81 (1H, d), 5.31 (1H, s), 4.01-4.30 (3H, m), 3.89 (1H, t), 3.52 (3H, s), 3.39-3.50 (2H, m), 2.63-2.49 (3H, m), 2.30 (2H, t), 2.00-1.71 (4H, m), 1.53 (2H, q), 1.28 (2H, m); 13C NMR (400 MHz, DMSO-d6) δ (ppm): 173.4, 160.6, 148.6, 145.8, 143.0, 113.6, 111.0, 109.7, 102.7, 78.9, 76.3, 73.6, 71.5, 63.4, 40.7, 38.3, 34.0, 29.3, 28.1; MS (ESI) for (M+H)+: 529.12 1 H NMR (400 MHz, DMSO-d6) δ (ppm): 7.74 (1H, d), 6.87 (1H, s), 6.73 (1H, s), 5.90 (1H, d), 5.81 (1H, d) , 5.31 (1H, s), 4.01-4.30 (3H, m), 3.89 (1H, t), 3.52 (3H, s), 3.39-3.50 (2H, m), 2.63-2.49 (3H, m), 2.30 (2H, t), 2.00-1.71 (4H, m), 1.53 (2H, q), 1.28 (2H, m); 13 C NMR (400 MHz, DMSO-d 6 ) δ (ppm): 173.4, 160.6, 148.6, 145.8, 143.0, 113.6, 111.0, 109.7, 102.7, 78.9, 76.3, 73.6, 71.5, 63.4, 40.7, 38.3, 34.0, 29.3, 28.1; MS (ESI) for (M + H) + : 529.12

〔実施例2〕
エスクリンリポ酸エステルの調製
[Example 2]
Preparation of esculin lipoate

エスクリン100mg(0.29mmol)およびリポ酸66.6mg(0.32mmol)を100mL反応器に入れた。アセトニトリル60mLを添加して反応混合物を形成した。次いで、DCC61.9mg(0.3mmol)および塩化ベンジルトリエチルアンモニウム(TEBAC)6.7mgを反応混合物に添加した。反応混合物を超音波処理および窒素雰囲気下で45℃で4時間加熱した。反応混合物を室温に冷却し、減圧下で濃縮し、濾過し、硫酸ナトリウムで乾燥した。次いで反応混合物中の溶媒を除去して、エスクリンリポ酸エステル121.3mgを得た(収率78.14%)。   100 mg (0.29 mmol) of esculin and 66.6 mg (0.32 mmol) of lipoic acid were placed in a 100 mL reactor. 60 mL of acetonitrile was added to form a reaction mixture. Then 61.9 mg (0.3 mmol) of DCC and 6.7 mg of benzyltriethylammonium chloride (TEBAC) were added to the reaction mixture. The reaction mixture was heated at 45 ° C. under sonication and a nitrogen atmosphere for 4 hours. The reaction mixture was cooled to room temperature, concentrated under reduced pressure, filtered, and dried over sodium sulfate. Next, the solvent in the reaction mixture was removed to obtain 121.3 mg of esculin lipoic acid ester (78.14% yield).

〔実施例3〕
エスクリンリポ酸エステルの調製
[Example 3]
Preparation of esculin lipoate

エスクリン100mg(0.29mmol)およびリポ酸78.7mg(0.38mmol)を100mL反応器に入れた。アセトニトリル60mLを添加して反応混合物を形成した。次いで、DCC61.9mg(0.3mmol)および塩化チオニル3.5mgを反応混合物に添加した。反応混合物を超音波処理および窒素雰囲気下で55℃で3時間加熱した。反応混合物を室温に冷却し、減圧下で濃縮し、濾過し、硫酸ナトリウムで乾燥した。次いで反応混合物中の溶媒を除去して、エスクリンリポ酸エステル129.3mgを得た(収率83.26%)。   100 mg (0.29 mmol) of esculin and 78.7 mg (0.38 mmol) of lipoic acid were placed in a 100 mL reactor. 60 mL of acetonitrile was added to form a reaction mixture. Then 61.9 mg (0.3 mmol) of DCC and 3.5 mg of thionyl chloride were added to the reaction mixture. The reaction mixture was sonicated and heated at 55 ° C. under a nitrogen atmosphere for 3 hours. The reaction mixture was cooled to room temperature, concentrated under reduced pressure, filtered, and dried over sodium sulfate. Next, the solvent in the reaction mixture was removed to obtain 129.3 mg of esculin lipoic acid ester (83.26% yield).

〔実施例4〕
エスクリンリポ酸エステルの調製
[Example 4]
Preparation of esculin lipoate

エスクリン100mg(0.29mmol)およびリポ酸66.6mg(0.32mmol)を100mL反応器に入れた。アセトニトリル60mLを添加して反応混合物を形成した。次いで、DCC61.9mg(0.3mmol)および塩化チオニル3.5mgを反応混合物に添加した。反応混合物を超音波処理および窒素雰囲気下で30℃で3時間加熱した。反応混合物を室温に冷却し、減圧下で濃縮し、濾過し、硫酸ナトリウムで乾燥した。次いで反応混合物中の溶媒を除去してエスクリンリポ酸エステル124.4mgを得た(収率80.11%)。   100 mg (0.29 mmol) of esculin and 66.6 mg (0.32 mmol) of lipoic acid were placed in a 100 mL reactor. 60 mL of acetonitrile was added to form a reaction mixture. Then 61.9 mg (0.3 mmol) of DCC and 3.5 mg of thionyl chloride were added to the reaction mixture. The reaction mixture was heated at 30 ° C. for 3 hours under sonication and nitrogen atmosphere. The reaction mixture was cooled to room temperature, concentrated under reduced pressure, filtered, and dried over sodium sulfate. Then, the solvent in the reaction mixture was removed to obtain 124.4 mg of esculin lipoate (yield: 80.11%).

〔実施例5〕
エスクリンリポ酸エステルの調製
[Example 5]
Preparation of esculin lipoate

エスクリン100mg(0.29mmol)およびリポ酸66.6mg(0.32mmol)を100mL反応器に入れた。アセトニトリル60mLを添加して反応混合物を形成した。次いで、DCC61.9mg(0.3mmol)および塩化ベンジルトリエチルアンモニウム(TEBAC)6.7mgを反応混合物に添加した。反応混合物を超音波処理および窒素雰囲気下で、50℃で4時間加熱した。反応混合物を室温に冷却し、減圧下で濃縮し、濾過し、硫酸ナトリウムで乾燥した。その後、反応混合物中の溶媒を除去して、エスクリンリポ酸エステル130.9mgを得た(収率84.28%)。   100 mg (0.29 mmol) of esculin and 66.6 mg (0.32 mmol) of lipoic acid were placed in a 100 mL reactor. 60 mL of acetonitrile was added to form a reaction mixture. Then 61.9 mg (0.3 mmol) of DCC and 6.7 mg of benzyltriethylammonium chloride (TEBAC) were added to the reaction mixture. The reaction mixture was heated at 50 ° C. for 4 hours under sonication and nitrogen atmosphere. The reaction mixture was cooled to room temperature, concentrated under reduced pressure, filtered, and dried over sodium sulfate. Thereafter, the solvent in the reaction mixture was removed to obtain 130.9 mg of esculin lipoate (84.28% yield).

〔実施例6〕
DPPHラジカルスカベンジング活性アッセイにより測定されるエスクリンリポ酸エステルの酸化防止活性
[Example 6]
Antioxidant activity of esculin lipoate as measured by DPPH radical scavenging activity assay

2,2−ジフェニル−1−ピクリルヒドラジル(DPPH)は安定な有機ラジカルからなる有機化合物である。DPPH分子においては、複数の電子求引性NOおよびベンゼン環の大きなπ結合の存在により、窒素フリーラジカルが安定化されている。そのメタノール溶液は紫色であり、517nmに最大吸収ピークを有する。酸化防止剤の添加後、DPPHは自由電子と対になる電子を捕獲し、紫色は退色して黄色の物質に変わる。517nmでの吸収は消え、退色の程度はそれが捕獲する電子の数と定量的に関係している。この原理に基づいて、分光光度計を使用してDPPHラジカルとサンプル溶液の吸光度の変化を検出し、サンプルが水素原子を供給してフリーラジカルを除去する能力を測定することができる。 2,2-Diphenyl-1-picrylhydrazyl (DPPH) is an organic compound composed of stable organic radicals. In the DPPH molecule, nitrogen free radicals are stabilized by the presence of a plurality of electron-withdrawing NO 2 and a large π bond of a benzene ring. The methanol solution is purple and has a maximum absorption peak at 517 nm. After addition of the antioxidant, DPPH captures electrons that are paired with free electrons, and the purple color fades to a yellow substance. The absorption at 517 nm disappears and the degree of fading is quantitatively related to the number of electrons it captures. Based on this principle, a spectrophotometer can be used to detect changes in DPPH radicals and the absorbance of the sample solution and determine the ability of the sample to supply hydrogen atoms and remove free radicals.

《DPPH溶液の調製》
正確な量の2,2−ジフェニル−1−ピクリルヒドラジル(DPPH)を測定し、メタノールに溶解して、0.2mmol/LのDPPH溶液を調製し、0℃で暗所に保存する。
<< Preparation of DPPH solution >>
An accurate amount of 2,2-diphenyl-1-picrylhydrazyl (DPPH) is measured, dissolved in methanol to prepare a 0.2 mmol / L DPPH solution, and stored at 0 ° C. in a dark place.

《サンプル溶液の調製》
エスクリンリポ酸エステルをアセトニトリルで1.82、7.28、24.2、48.4、72.6、96.8、242、484、726および968ppmの濃度勾配で希釈して、試験すべきサンプル溶液を調製した。対照サンプル(ビタミンC、エスクリン、リポ酸、エスクリンとリポ酸との混合物)をメタノールで同じ濃度勾配で同様に希釈して、対応する4群の対照溶液を得た。
<< Preparation of sample solution >>
The sample solution to be tested is prepared by diluting the esculin lipoate with acetonitrile in a gradient of 1.82, 7.28, 24.2, 48.4, 72.6, 96.8, 242, 484, 726 and 968 ppm. Was prepared. Control samples (vitamin C, esculin, lipoic acid, a mixture of esculin and lipoic acid) were similarly diluted with methanol at the same concentration gradient to obtain four corresponding groups of control solutions.

《具体的な工程:サンプル溶液のスカベンジング活性の測定》
各濃度勾配でサンプル溶液2mLを取り、0.2mmol/LのDPPH溶液2mLを添加し、混合物を混合し、室温で30分間暗所で反応させ、次いでメタノールを添加して最終容量を調整した。吸光度Aを517nmで測定した。対照溶液2mLとメタノール2mLとを混合し、吸光度Aを測定した。DPPH溶液2mLとメタノール2mLとを混合し、吸光度Aを測定した。サンプル溶液および対照溶液のスカベンジング活性は、以下の計算式に従って算出される。
スカベンジング活性(%)=100×[1−(A−A)/A
<< Specific process: Measurement of scavenging activity of sample solution >>
2 mL of the sample solution was taken at each concentration gradient, 2 mL of a 0.2 mmol / L DPPH solution was added, the mixture was mixed, allowed to react at room temperature for 30 minutes in the dark, and then methanol was added to adjust the final volume. The absorbance A i was measured at 517nm. 2 mL of the control solution and 2 mL of methanol were mixed, and the absorbance Aj was measured. Mixing the DPPH solution 2mL methanol 2mL, and the absorbance was measured A 0. The scavenging activity of the sample solution and the control solution is calculated according to the following formula.
Scavenging activity (%) = 100 × [1- (A i -A j ) / A 0 ]

スカベンジング活性を表1および図1に示す。図1において、X軸はサンプルおよび対照溶液の濃度(PPM)を表し、Y軸はスカベンジング活性を表す。   The scavenging activity is shown in Table 1 and FIG. In FIG. 1, the X-axis represents the concentration of the sample and the control solution (PPM), and the Y-axis represents the scavenging activity.

表1:スカベンジング活性

Figure 2020002127
Table 1: Scavenging activity
Figure 2020002127

試験結果は、エスクリンリポ酸エステルの酸化防止活性がビタミンCのそれと類似しており、90%を超えるフリーラジカルクリアランス率をより低い濃度で達成することができ、これは、エスクリン、リポ酸、およびエスクリンとリポ酸との混合物、より著しく高いことを示している。エスクリンリポ酸エステルは、食品および化粧品用酸化防止添加剤として使用することができ、幅広い用途の見込みがある。   The test results show that the antioxidant activity of esculin lipoate is similar to that of vitamin C, and that free radical clearance rates of more than 90% can be achieved at lower concentrations, due to esculin, lipoic acid, and esculin And a mixture of lipoic acid, showing significantly higher. Esculin lipoate can be used as an antioxidant additive for food and cosmetics and has widespread application prospects.

本発明の精神または範囲を逸脱することなく本発明に様々な修正および変更を加えることができることは当業者には明らかであろう。したがって、本発明は、添付の特許請求の範囲およびそれらの均等物の範囲内にある限り、本発明の修正形態および変形形態を網羅することを意図している。   It will be apparent to those skilled in the art that various modifications and variations can be made to the present invention without departing from the spirit or scope of the invention. Thus, it is intended that the present invention cover the modifications and variations of this invention provided they come within the scope of the appended claims and their equivalents.

Claims (4)

以下の式Iで示される化合物。
Figure 2020002127
A compound of the following formula I:
Figure 2020002127
式IIの化合物を式IIIの化合物と反応させて前記式Iの化合物を得ることを含む請求項1に記載の化合物を調製する方法。
Figure 2020002127
2. A method for preparing a compound according to claim 1, comprising reacting a compound of formula II with a compound of formula III to obtain said compound of formula I.
Figure 2020002127
前記式IIの化合物と前記式IIIの化合物との前記反応が、
前記式IIの化合物および前記式IIIの化合物を1:1〜1:1.3のモル比で反応器内に配する工程、
有機溶媒、N,N´−ジシクロヘキシルカルボジイミド、および触媒を添加して反応混合物を得る工程、ならびに、
超音波処理下で前記反応混合物を30〜55℃で3〜4時間加熱する工程、を含む請求項2に記載の方法。
Wherein the reaction of the compound of Formula II with the compound of Formula III comprises:
Disposing the compound of the formula II and the compound of the formula III in a reactor in a molar ratio of 1: 1 to 1: 1.3,
Adding an organic solvent, N, N′-dicyclohexylcarbodiimide, and a catalyst to obtain a reaction mixture; and
Heating the reaction mixture under sonication at 30-55 ° C for 3-4 hours.
前記有機溶媒がアセトニトリルまたはTHFであり、前記触媒が塩化ベンジルトリエチルアンモニウムまたは塩化チオニルである請求項3に記載の方法。   The method according to claim 3, wherein the organic solvent is acetonitrile or THF, and the catalyst is benzyltriethylammonium chloride or thionyl chloride.
JP2019115839A 2018-06-22 2019-06-21 Esculin lipoic acid ester having antioxidant activity and method for producing the same Expired - Fee Related JP6741315B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201810649366.X 2018-06-22
CN201810649366.XA CN108794459A (en) 2018-06-22 2018-06-22 A kind of aesculin lipoate compound and preparation method thereof with antioxidant activity

Publications (2)

Publication Number Publication Date
JP2020002127A true JP2020002127A (en) 2020-01-09
JP6741315B2 JP6741315B2 (en) 2020-08-19

Family

ID=64084269

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019115839A Expired - Fee Related JP6741315B2 (en) 2018-06-22 2019-06-21 Esculin lipoic acid ester having antioxidant activity and method for producing the same

Country Status (2)

Country Link
JP (1) JP6741315B2 (en)
CN (1) CN108794459A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109620840A (en) * 2018-12-27 2019-04-16 江苏隆力奇生物科技股份有限公司 A kind of pharmaceutical composition and its application of anti-skin photoage
CN113214194A (en) * 2021-04-14 2021-08-06 张洪胜 Andrographolide gallate compound with antioxidant activity and preparation method thereof

Also Published As

Publication number Publication date
CN108794459A (en) 2018-11-13
JP6741315B2 (en) 2020-08-19

Similar Documents

Publication Publication Date Title
JP6741315B2 (en) Esculin lipoic acid ester having antioxidant activity and method for producing the same
Rodriguez-Naranjo et al. Comparative evaluation of the antioxidant activity of melatonin and related indoles
US9174983B2 (en) Pyrroloquinoline quinone disodium salt crystal and method for producing the same
AU2014278362B2 (en) Preparation of (S,S)-secoisolariciresinol diglucoside and (R,R)-secoisolariciresinol diglucoside
Li et al. Synthesis, characterization, solubilization, cytotoxicity and antioxidant activity of aminomethylated dihydroquercetin
CN111643452A (en) Oxyresveratrol nanoemulsion as well as preparation method and application thereof
JP6940197B2 (en) Hydroxytyrosol dihydrocafe art with antioxidant activity and its preparation method
CN107674056A (en) Its application in hyperuricemia is treated of Versulin derivative
JP6893051B6 (en) Hydroxytyrosol isophorone diisocyanate derivative with antioxidant activity and its preparation method
CN112812121B (en) Pyridone modified zinc phthalocyanine and preparation method and application thereof
CN109942395A (en) A kind of curcumin ionic liquid and its application
US10208077B1 (en) Aesculin lipoic acid ester with antioxidant activity and a method of preparing the same
US10208078B1 (en) Aesculin thiodipropionic acid ester with antioxidant activity and a method of preparing the same
US10487094B1 (en) Bergenin thiodipropionic acid ester with antioxidant activity and a method of improving the antioxidant property of ganoderma lucidum spore oil using the same
JP6125532B2 (en) Acridinedione derivatives for the treatment of pigmentation diseases and skin aging
US10995053B1 (en) Hydroxytyrosol ursolic acid ester with antioxidant activity and methods of preparing the same
CN108484471B (en) Compound for dyeing hair and single-agent hair dye containing compound
CN102898503B (en) Antioxidation-activity synthetic peptides and application thereof
KR102423643B1 (en) Method For Astaxanthin Monoester Through Transesterification
US10494377B1 (en) Bergenin lipoic acid ester with antioxidant activity and a method of preparing the same
KR101931442B1 (en) A novel compound having anti-oxidant or anti-inflammatory activity
CN114716400B (en) Cosmetic active substance tocopheryl ester and green synthesis method thereof
US10343988B1 (en) Hydroxytyrosol thiodipropionic acid ester with antioxidant activity and a method of preparing the same
CN108440644B (en) Porphyrin dimer with high water solubility and application thereof
CN111328281B (en) Polyketide and derivatives thereof for preventing and treating neurological disorders

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190621

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20200630

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20200720

R150 Certificate of patent or registration of utility model

Ref document number: 6741315

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees